A groundbreaking gene therapy for lupus could eliminate the need for lifelong medication for patients. Administered in Germany and the UK, the CAR T-cell treatment has shown promising results, with some patients entering remission and no longer requiring medication. Affecting approximately 5 million people worldwide, lupus primarily targets women and can cause severe organ damage. Patient Katie Tinkler, who has battled the disease for 30 years, reported significant improvements in energy levels and joint pain. Researchers continue to monitor patients over 15 years to assess long-term effects, hoping this treatment revolutionizes care for lupus.